PLx Pharma Inc. Reports First Quarter 2022 Results and Provides Business Update - read this article along with other careers information, tips and advice on BioSpace
PLx Pharma (PLXP) Reports Q1 Revenue of $2 1M, EPS of ($0 66) streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
13.05.2022 - BUILDING A SOLID BASE OF VAZALORE USERS Total Net Sales of $2.1 Million in the First Quarter of 2022, an Increase of Approximately 31% from Fourth Quarter of 2021GAAP Net Loss of ($0.39) Per Diluted Share in the First Quarter 2022; Adjusted .